Repro Med Systems Inc
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating p… Read more
Market Cap & Net Worth: Repro Med Systems Inc (KRMD)
Repro Med Systems Inc (NASDAQ:KRMD) has a market capitalization of $197.80 Million ($197.80 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16609 globally and #6377 in its home market, demonstrating a -7.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Repro Med Systems Inc's stock price $4.27 by its total outstanding shares 46322655 (46.32 Million).
Repro Med Systems Inc Market Cap History: 2015 to 2026
Repro Med Systems Inc's market capitalization history from 2015 to 2026. Data shows growth from $25.48 Million to $197.80 Million (25.83% CAGR).
Index Memberships
Repro Med Systems Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.01% | #447 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1555 of 3165 |
Weight: Repro Med Systems Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Repro Med Systems Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Repro Med Systems Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.30x
Repro Med Systems Inc's market cap is 5.30 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $25.48 Million | $12.25 Million | $782.86K | 2.08x | 32.54x |
| 2016 | $23.16 Million | $12.29 Million | -$535.00K | 1.88x | N/A |
| 2017 | $57.90 Million | $15.98 Million | $1.09 Million | 3.62x | 53.32x |
| 2018 | $76.43 Million | $17.35 Million | $910.57K | 4.40x | 83.94x |
| 2019 | $302.49 Million | $23.16 Million | $564.35K | 13.06x | 535.99x |
| 2020 | $278.86 Million | $24.18 Million | -$1.21 Million | 11.53x | N/A |
| 2021 | $138.97 Million | $23.49 Million | -$4.56 Million | 5.92x | N/A |
| 2022 | $165.37 Million | $27.90 Million | -$8.66 Million | 5.93x | N/A |
| 2023 | $113.72 Million | $28.52 Million | -$13.74 Million | 3.99x | N/A |
| 2024 | $178.34 Million | $33.65 Million | -$6.07 Million | 5.30x | N/A |
Competitor Companies of KRMD by Market Capitalization
Companies near Repro Med Systems Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Repro Med Systems Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Repro Med Systems Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Repro Med Systems Inc's market cap moved from $25.48 Million to $ 197.80 Million, with a yearly change of 25.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $197.80 Million | -26.51% |
| 2025 | $269.13 Million | +50.91% |
| 2024 | $178.34 Million | +56.82% |
| 2023 | $113.72 Million | -31.23% |
| 2022 | $165.37 Million | +19.00% |
| 2021 | $138.97 Million | -50.17% |
| 2020 | $278.86 Million | -7.81% |
| 2019 | $302.49 Million | +295.76% |
| 2018 | $76.43 Million | +32.00% |
| 2017 | $57.90 Million | +150.00% |
| 2016 | $23.16 Million | -9.09% |
| 2015 | $25.48 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Repro Med Systems Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $197.80 Million USD |
| MoneyControl | $197.80 Million USD |
| MarketWatch | $197.80 Million USD |
| marketcap.company | $197.80 Million USD |
| Reuters | $197.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.